Literature DB >> 12508936

Osteoporosis treatment in elderly hyperthyroid male patients.

M R Fittipaldi1, F Fonderico, G Vitale, A Ciccarelli, G A Lupoli, T Cascella, A Panico, G Lupoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12508936

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.

Authors:  Takafumi Majima; Yasato Komatsu; Kentaro Doi; Chieko Takagi; Michika Shigemoto; Atsushi Fukao; Takeshi Morimoto; Jerry Corners; Kazuwa Nakao
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.

Authors:  T Majima; Y Komatsu; K Doi; C Takagi; M Shigemoto; A Fukao; T Morimoto; J Corners; K Nakao
Journal:  Osteoporos Int       Date:  2006-04-07       Impact factor: 4.507

3.  Metabolic and clinical consequences of hyperthyroidism on bone density.

Authors:  Jagoda Gorka; Regina M Taylor-Gjevre; Terra Arnason
Journal:  Int J Endocrinol       Date:  2013-07-22       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.